Source: Pharmacology research & perspectives. Unidades: FM, FZEA
Subjects: REPERFUSÃO, FÁRMACOS SINTÉTICOS, FÍGADO
ABNT
MOSCOSO, Agustin Vintimilla et al. Hexafluoroisopropanol decreases liver ischemia-reperfusion injury by downregulation of high mobility group box-1 protein. Pharmacology research & perspectives, v. 10, n. 6, 2022Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/50527. Acesso em: 14 out. 2024.APA
Moscoso, A. V., Figueira, E. R. R., Rocha-filho, J. A., Urner, M., Lanchotte, C., Jukemura, J., et al. (2022). Hexafluoroisopropanol decreases liver ischemia-reperfusion injury by downregulation of high mobility group box-1 protein. Pharmacology research & perspectives, 10( 6). doi:10.1002/prp2.1027NLM
Moscoso AV, Figueira ERR, Rocha-filho JA, Urner M, Lanchotte C, Jukemura J, Ximenes JLS, Nahas SC, D'albuquerque LAC, Galvão FHF. Hexafluoroisopropanol decreases liver ischemia-reperfusion injury by downregulation of high mobility group box-1 protein [Internet]. Pharmacology research & perspectives. 2022 ; 10( 6):[citado 2024 out. 14 ] Available from: https://observatorio.fm.usp.br/handle/OPI/50527Vancouver
Moscoso AV, Figueira ERR, Rocha-filho JA, Urner M, Lanchotte C, Jukemura J, Ximenes JLS, Nahas SC, D'albuquerque LAC, Galvão FHF. Hexafluoroisopropanol decreases liver ischemia-reperfusion injury by downregulation of high mobility group box-1 protein [Internet]. Pharmacology research & perspectives. 2022 ; 10( 6):[citado 2024 out. 14 ] Available from: https://observatorio.fm.usp.br/handle/OPI/50527